
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $11B | $11.6B | $11.1B | $11.3B | $11.2B | |
Revenue Growth (YoY) | -7.42% | 4.78% | -3.82% | 2% | -1.15% | |
Cost of Revenues | $6.5B | $6.8B | $6.9B | $7.1B | $6.9B | |
Gross Profit | $4.5B | $4.8B | $4.2B | $4.2B | $4.3B | |
Gross Profit Margin | 41.07% | 41.23% | 38.09% | 37.07% | 38.12% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $3.6B | $3.6B | $3.2B | $3.2B | $3.2B | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $3.6B | $3.7B | $3.2B | $3.2B | $3.2B | |
Operating Income | $901.9M | $1.1B | $1.1B | $1B | $1.1B | |
Net Interest Expenses | $18.8M | $13.8M | $3M | -- | -- | |
EBT. Incl. Unusual Items | $882.2M | $1.1B | $1.1B | $1B | $1.1B | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $279.9M | $310.1M | $292.9M | $265.9M | $287M | |
Net Income to Company | $882.2M | $1.1B | $1.1B | $1B | $1.1B | |
Minority Interest in Earnings | -$113.2M | -$130.8M | -$144M | -$154.9M | -$159.5M | |
Net Income to Common Excl Extra Items | $489.2M | $625.9M | $631.3M | $589.7M | $618M | |
Basic EPS (Cont. Ops) | $0.79 | $1.01 | $1.02 | $0.95 | $1.00 | |
Diluted EPS (Cont. Ops) | $0.79 | $1.01 | $1.02 | $0.95 | $1.00 | |
Weighted Average Basic Share | $618M | $618M | $618M | $618M | $618M | |
Weighted Average Diluted Share | $618M | $618M | $618M | $618M | $618M | |
EBITDA | $1.6B | $1.7B | $1.6B | $1.6B | $1.6B | |
EBIT | $909.1M | $1.1B | $1.1B | $1B | $1.1B | |
Revenue (Reported) | $11B | $11.6B | $11.1B | $11.3B | $11.2B | |
Operating Income (Reported) | $901.9M | $1.1B | $1.1B | $1B | $1.1B | |
Operating Income (Adjusted) | $909.1M | $1.1B | $1.1B | $1B | $1.1B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $2.5B | $2.5B | $2.6B | $2.5B | $2.4B | |
Revenue Growth (YoY) | 0.06% | 0.03% | 0.2% | -1.91% | -22.01% | |
Cost of Revenues | $1.5B | $1.6B | $1.6B | $1.6B | $1.5B | |
Gross Profit | $1.1B | $993.1M | $940.7M | $937.8M | $909.4M | |
Gross Profit Margin | 41.23% | 38.98% | 36.85% | 37.45% | 37.91% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $861.9M | $807.4M | $741.6M | $714.2M | $723.5M | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $863.4M | $807.3M | $744.9M | $712.4M | $732.2M | |
Operating Income | $186.8M | $185.8M | $195.8M | $225.4M | $177.3M | |
Net Interest Expenses | $2.6M | $1.2M | -- | -- | $3.7M | |
EBT. Incl. Unusual Items | $184.4M | $185M | $200.7M | $233.5M | $175.3M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $47.1M | $46.3M | $53.8M | $59.1M | $41.7M | |
Net Income to Company | $184.4M | $185M | $200.7M | $233.5M | $175.3M | |
Minority Interest in Earnings | -$36.6M | -$32.4M | -$36.5M | -$37.9M | -$32.5M | |
Net Income to Common Excl Extra Items | $100.7M | $106.3M | $110.4M | $136.5M | $101.1M | |
Basic EPS (Cont. Ops) | $0.16 | $0.17 | $0.18 | $0.22 | $0.16 | |
Diluted EPS (Cont. Ops) | $0.16 | $0.17 | $0.18 | $0.22 | $0.16 | |
Weighted Average Basic Share | $618M | $618M | $618M | $618M | $617.9M | |
Weighted Average Diluted Share | $618M | $618M | $618M | $618M | $617.9M | |
EBITDA | $353.1M | $339.9M | $341.4M | $364M | $314.5M | |
EBIT | $188.9M | $189.4M | $205.7M | $240.2M | $184.6M | |
Revenue (Reported) | $2.5B | $2.5B | $2.6B | $2.5B | $2.4B | |
Operating Income (Reported) | $186.8M | $185.8M | $195.8M | $225.4M | $177.3M | |
Operating Income (Adjusted) | $188.9M | $189.4M | $205.7M | $240.2M | $184.6M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $11B | $11.5B | $11B | $11.3B | $10.5B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $6.5B | $6.8B | $6.9B | $7.1B | $6.5B | |
Gross Profit | $4.5B | $4.7B | $4.2B | $4.2B | $3.9B | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $3.6B | $3.6B | $3.1B | $3.1B | $3B | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $3.6B | $3.6B | $3.1B | $3.2B | $3.1B | |
Operating Income | $907.8M | $1.1B | $1.1B | $1B | $876M | |
Net Interest Expenses | $20.7M | $12.3M | $803.9K | -- | $3.9M | |
EBT. Incl. Unusual Items | $886.3M | $1.1B | $1.1B | $1B | $874.3M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $290.8M | $309.4M | $298.5M | $272.3M | $211.4M | |
Net Income to Company | $885.3M | $1.1B | $1.1B | $1B | $895.8M | |
Minority Interest in Earnings | -$123.1M | -$126.7M | -$147.3M | -$156.5M | -$151.5M | |
Net Income to Common Excl Extra Items | $472.5M | $631.7M | $632.2M | $614.6M | $511.4M | |
Basic EPS (Cont. Ops) | $0.76 | $1.02 | $1.02 | $0.99 | $0.83 | |
Diluted EPS (Cont. Ops) | $0.76 | $1.02 | $1.02 | $0.99 | $0.83 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $1.6B | $1.7B | $1.6B | $1.6B | $1.4B | |
EBIT | $911.9M | $1.1B | $1.1B | $1.1B | $911.1M | |
Revenue (Reported) | $11B | $11.5B | $11B | $11.3B | $10.5B | |
Operating Income (Reported) | $907.8M | $1.1B | $1.1B | $1B | $876M | |
Operating Income (Adjusted) | $911.9M | $1.1B | $1.1B | $1.1B | $911.1M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $2.5B | $2.5B | $2.6B | $2.5B | $2.4B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $1.5B | $1.6B | $1.6B | $1.6B | $1.5B | |
Gross Profit | $1.1B | $993.1M | $940.7M | $937.8M | $909.4M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $861.9M | $807.4M | $741.6M | $714.2M | $723.5M | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $863.4M | $807.3M | $744.9M | $712.4M | $732.2M | |
Operating Income | $186.8M | $185.8M | $195.8M | $225.4M | $177.3M | |
Net Interest Expenses | $2.6M | $1.2M | -- | -- | $3.7M | |
EBT. Incl. Unusual Items | $184.4M | $185M | $200.7M | $233.5M | $175.3M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $47.1M | $46.3M | $53.8M | $59.1M | $41.7M | |
Net Income to Company | $184.4M | $185M | $200.7M | $233.5M | $175.3M | |
Minority Interest in Earnings | -$36.6M | -$32.4M | -$36.5M | -$37.9M | -$32.5M | |
Net Income to Common Excl Extra Items | $100.7M | $106.3M | $110.4M | $136.5M | $101.1M | |
Basic EPS (Cont. Ops) | $0.16 | $0.17 | $0.18 | $0.22 | $0.16 | |
Diluted EPS (Cont. Ops) | $0.16 | $0.17 | $0.18 | $0.22 | $0.16 | |
Weighted Average Basic Share | $618M | $618M | $618M | $618M | $617.9M | |
Weighted Average Diluted Share | $618M | $618M | $618M | $618M | $617.9M | |
EBITDA | $353.1M | $339.9M | $341.4M | $364M | $314.5M | |
EBIT | $188.9M | $189.4M | $205.7M | $240.2M | $184.6M | |
Revenue (Reported) | $2.5B | $2.5B | $2.6B | $2.5B | $2.4B | |
Operating Income (Reported) | $186.8M | $185.8M | $195.8M | $225.4M | $177.3M | |
Operating Income (Adjusted) | $188.9M | $189.4M | $205.7M | $240.2M | $184.6M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $1.6B | $1.5B | $1.5B | $1.2B | $1B | |
Short Term Investments | $7M | $10.9M | $23.8M | $11.8M | $29M | |
Accounts Receivable, Net | $1.9B | $2.1B | $2.1B | $2.2B | $2.2B | |
Inventory | $768.5M | $763M | $809.1M | $822.3M | $754M | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $227.8M | $208.2M | $195M | $199.8M | $217.8M | |
Total Current Assets | $4.5B | $4.6B | $4.6B | $4.5B | $4.2B | |
Property Plant And Equipment | $4B | $3.7B | $3.3B | $3.3B | $3.5B | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $2.4B | $2.2B | $2B | $2B | $1.8B | |
Other Intangibles | $3.9B | $3.7B | $3.5B | $3.5B | $3.4B | |
Other Long-Term Assets | $91.4M | $64M | $54.4M | $55.9M | $48.2M | |
Total Assets | $15.3B | $14.6B | $13.6B | $13.6B | $13.1B | |
Accounts Payable | $3B | $3.1B | $2.9B | $3.1B | $2.9B | |
Accrued Expenses | -- | -- | -- | -- | -- | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | $48.4M | $48.1M | $63M | $43.3M | $42.9M | |
Total Current Liabilities | $4.3B | $4B | $3.8B | $3.8B | $3.5B | |
Long-Term Debt | $1.2B | $952.1M | $493.9M | $177.3M | $3.5M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $6.9B | $6.4B | $5.5B | $5.2B | $4.7B | |
Common Stock | $1.6B | $1.5B | $1.3B | $1.2B | $1.1B | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | $7.6B | $7.5B | $7.4B | $7.7B | $7.7B | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $754.4M | $724.4M | $723.7M | $692.5M | $673M | |
Total Equity | $8.3B | $8.2B | $8.1B | $8.4B | $8.4B | |
Total Liabilities and Equity | $15.3B | $14.6B | $13.6B | $13.6B | $13.1B | |
Cash and Short Terms | $1.6B | $1.5B | $1.6B | $1.2B | $1.1B | |
Total Debt | $2B | $1.4B | $936.2M | $527.8M | $173.3M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $1.6B | $1.3B | $1.4B | $1B | $844.2M | |
Short Term Investments | $7.6M | $13.2M | $22.9M | $20.7M | $19.8M | |
Accounts Receivable, Net | $1.7B | $1.8B | $2B | $2.1B | $2B | |
Inventory | $786.9M | $814.4M | $920.6M | $836.9M | $904.5M | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $206M | $207.6M | $204.4M | $225.2M | $268.4M | |
Total Current Assets | $4.3B | $4.3B | $4.5B | $4.2B | $4.1B | |
Property Plant And Equipment | $3.9B | $3.5B | $3.3B | $3.3B | $3.5B | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $2.3B | $2.1B | $2B | $1.9B | $1.9B | |
Other Intangibles | $3.9B | $3.7B | $3.5B | $3.4B | $3.4B | |
Other Long-Term Assets | $76.7M | $59.7M | $56.5M | $54.9M | $50M | |
Total Assets | $14.8B | $13.9B | $13.5B | $13.1B | $13.2B | |
Accounts Payable | $2.9B | $2.8B | $2.8B | $2.8B | $2.8B | |
Accrued Expenses | -- | -- | -- | -- | -- | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | $52.5M | $55.6M | $66.8M | $59.9M | $56.8M | |
Total Current Liabilities | $4.3B | $3.6B | $3.7B | $3.5B | $3.3B | |
Long-Term Debt | $1B | $899.1M | $487.3M | $169.6M | $3.6M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $6.7B | $5.8B | $5.3B | $4.9B | $4.6B | |
Common Stock | $1.5B | $1.4B | $1.3B | $1.1B | $1.1B | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $776.6M | $755.9M | $759.8M | $706.7M | $700.3M | |
Total Equity | $8.1B | $8.1B | $8.1B | $8.2B | $8.6B | |
Total Liabilities and Equity | $14.8B | $13.9B | $13.5B | $13.1B | $13.2B | |
Cash and Short Terms | $1.6B | $1.3B | $1.4B | $1B | $864M | |
Total Debt | $1.9B | $1.2B | $915.1M | $527.5M | $175.8M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $882.2M | $1.1B | $1.1B | $1B | $1.1B | |
Depreciation & Amoritzation | $661.9M | $632.3M | $542.9M | $520.9M | $508.6M | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -$52.1M | -$333.9M | -$181.1M | -$209M | -$136.9M | |
Change in Inventories | $47.4M | -$50.2M | -$147.3M | -$33.4M | $14.1M | |
Cash From Operations | $1.3B | $1.4B | $1.2B | $1.1B | $1.3B | |
Capital Expenditures | $585.4M | $511.5M | $461.9M | $564.8M | $715.9M | |
Cash Acquisitions | -- | -$20.3M | $141.1M | $4.5M | $31.1M | |
Cash From Investing | -$573.5M | -$518.3M | -$325.1M | -$554.5M | -$669.5M | |
Dividends Paid (Ex Special Dividend) | -- | -$219.7M | -$184.8M | -$178.4M | -$194M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $281.1M | $283.6M | $50.8M | -- | -- | |
Long-Term Debt Repaid | -$535.8M | -$390.3M | -$336.1M | -$320.7M | -$270.5M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$168.6K | -$9.1K | -$23K | -$14.3K | -$14.3M | |
Cash From Financing | -$438M | -$875.9M | -$707.1M | -$822.5M | -$740.5M | |
Beginning Cash (CF) | $1.3B | $1.5B | $1.4B | $1.4B | $1.1B | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $244M | $47.4M | $122M | -$248.8M | -$129.6M | |
Ending Cash (CF) | $1.6B | $1.6B | $1.5B | $1.2B | $1.1B | |
Levered Free Cash Flow | $670.2M | $930.2M | $692.3M | $563.5M | $564.6M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $184.4M | $185M | $200.7M | $233.5M | $175.3M | |
Depreciation & Amoritzation | $164.2M | $150.5M | $135.7M | $123.8M | $129.9M | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | $95.4M | $212.7M | $57.2M | $7M | $219.9M | |
Change in Inventories | -$51.4M | -$123.8M | -$115.5M | -$52.2M | -$128.6M | |
Cash From Operations | $327M | $263.8M | $95.4M | $71M | $75.5M | |
Capital Expenditures | $105.9M | $104.6M | $111.6M | $156.9M | $125M | |
Cash Acquisitions | -$20.4M | -- | $3.6M | $6.7M | -- | |
Cash From Investing | -$128.1M | -$103.2M | -$107.5M | -$140.9M | -$116.9M | |
Dividends Paid (Ex Special Dividend) | -$113.8M | -$103.7M | -$95.9M | -$83.3M | -$131.7M | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $20.8M | -- | -- | -- | -- | |
Long-Term Debt Repaid | -$171M | -$109.9M | -- | -$235.8K | -$131.2K | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -$17.2K | -$7.6K | -$6.7K | -$52.5K | |
Cash From Financing | -$142.7M | -$294.3M | -$133M | -$76.7M | -$160.2M | |
Beginning Cash (CF) | $1.6B | $1.5B | $1.5B | $1.2B | $1.1B | |
Foreign Exchange Rate Adjustment | $27.9M | $37.2M | $5.2M | $22.3M | -$22.5M | |
Additions / Reductions | $56.2M | -$133.7M | -$145.2M | -$146.7M | -$201.6M | |
Ending Cash (CF) | $1.7B | $1.4B | $1.4B | $1B | $828.4M | |
Levered Free Cash Flow | $221.2M | $159.2M | -$16.2M | -$85.9M | -$49.5M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $885.3M | $1.1B | $1.1B | $1B | $895.8M | |
Depreciation & Amoritzation | $662.6M | $618.6M | $528.1M | $508.9M | $519.8M | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -$86M | -$216.6M | -$336.6M | -$259.3M | $256.3M | |
Change in Inventories | $92.8M | -$122.5M | -$139.1M | $29.9M | -$187M | |
Cash From Operations | $1.5B | $1.4B | $985.7M | $1.1B | $837.8M | |
Capital Expenditures | $535.5M | $510.3M | $468.8M | $610.1M | $684.4M | |
Cash Acquisitions | -$20.4M | $115.2K | $144.7M | $7.6M | $27.8M | |
Cash From Investing | -$549.4M | -$493.4M | -$329.4M | -$588M | -$634.7M | |
Dividends Paid (Ex Special Dividend) | -$113.8M | -$209.6M | -$177M | -$165.8M | -$216.1M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $301.9M | -- | -- | -- | -- | |
Long-Term Debt Repaid | -$411.2M | -$329.2M | -$226.2M | -$321M | -$143.3M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -$26.3K | -$13.4K | -$13.4K | -$58.8K | |
Cash From Financing | -$518.8M | -$1B | -$545.9M | -$766.2M | -$418.3M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $383.7M | -$142.5M | $110.5M | -$250.3M | -$215.2M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | $916.4M | $868.2M | $516.9M | $493.8M | $153.4M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $184.4M | $185M | $200.7M | $233.5M | $175.3M | |
Depreciation & Amoritzation | $164.2M | $150.5M | $135.7M | $123.8M | $129.9M | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | $95.4M | $212.7M | $57.2M | $7M | $219.9M | |
Change in Inventories | -$51.4M | -$123.8M | -$115.5M | -$52.2M | -$128.6M | |
Cash From Operations | $327M | $263.8M | $95.4M | $71M | $75.5M | |
Capital Expenditures | $105.9M | $104.6M | $111.6M | $156.9M | $125M | |
Cash Acquisitions | -$20.4M | -- | $3.6M | $6.7M | -- | |
Cash From Investing | -$128.1M | -$103.2M | -$107.5M | -$140.9M | -$116.9M | |
Dividends Paid (Ex Special Dividend) | -$113.8M | -$103.7M | -$95.9M | -$83.3M | -$131.7M | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $20.8M | -- | -- | -- | -- | |
Long-Term Debt Repaid | -$171M | -$109.9M | -- | -$235.8K | -$131.2K | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -$17.2K | -$7.6K | -$6.7K | -$52.5K | |
Cash From Financing | -$142.7M | -$294.3M | -$133M | -$76.7M | -$160.2M | |
Beginning Cash (CF) | $1.6B | $1.5B | $1.5B | $1.2B | $1.1B | |
Foreign Exchange Rate Adjustment | $27.9M | $37.2M | $5.2M | $22.3M | -$22.5M | |
Additions / Reductions | $56.2M | -$133.7M | -$145.2M | -$146.7M | -$201.6M | |
Ending Cash (CF) | $1.7B | $1.4B | $1.4B | $1B | $828.4M | |
Levered Free Cash Flow | $221.2M | $159.2M | -$16.2M | -$85.9M | -$49.5M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.